Request Deal Involvement
Johnson & Johnson completed the acquisition of Yellow Jersey Therapeutics from RTW-backed Numab Therapeutics for $1.25bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Lyra Strategic Advisory
financial advisors
Centerview Partners
pr advisors
Meru Advisors
financial advisors
Morgan Stanley
legal advisors
Baker McKenzie
pr advisors
Gasthalter & Co
or
Principals
bidder
JOHNSON & JOHNSON
target
YELLOW JERSEY THERAPEUTICS
vendor
NUMAB THERAPEUTICS
vendor
RTW INVESTMENTS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite